Literature DB >> 8645290

Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes.

J M Stouthard1, R P Oude Elferink, H P Sauerwein.   

Abstract

To study the effect of interleukin-6 (IL-6) on glucose transport, 2-deoxy-D-glucose (2-DOG) uptake in 3T3-L1 adipocytes after incubation with IL-6 was measured. IL-6 increased 2-DOG uptake maximally after 5 hours by 30 +/- 12%, with a half-maximal effect at an IL-6 concentration of approximately 800 U/mL. 3-O-methylglucose uptake was stimulated in a similar way, indicating that IL-6 enhanced glucose transport rather than phosphorylation. IL-6-induced glucose transport was additive to the effect of insulin. Addition of cycloheximide did not affect the stimulatory action of IL-6, although cycloheximide itself had profound effects on basal glucose transport. We conclude that IL-6 may enhance glucose uptake by increasing GLUT-1 intrinsic activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645290     DOI: 10.1006/bbrc.1996.0389

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

Review 1.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

Review 2.  IL-6 and metabolism-new evidence and new questions.

Authors:  A Krook
Journal:  Diabetologia       Date:  2008-07       Impact factor: 10.122

3.  IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1 adipocytes.

Authors:  Chenbo Ji; Xiaohui Chen; Chunlin Gao; Liuhong Jiao; Jianguo Wang; Guangfeng Xu; Hailong Fu; Xirong Guo; Yaping Zhao
Journal:  J Bioenerg Biomembr       Date:  2011-07-06       Impact factor: 2.945

4.  Nr4a1 siRNA expression attenuates α-MSH regulated gene expression in 3T3-L1 adipocytes.

Authors:  S-C Mary Wang; Stephen A Myers; Natalie A Eriksson; Rebecca L Fitzsimmons; George E O Muscat
Journal:  Mol Endocrinol       Date:  2011-01-14

5.  Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content.

Authors:  A Steensberg; M A Febbraio; T Osada; P Schjerling; G van Hall; B Saltin; B K Pedersen
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

6.  Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans.

Authors:  Adam Steensberg; Christian P Fischer; Massimo Sacchetti; Charlotte Keller; Takuya Osada; Peter Schjerling; Gerrit van Hall; Mark A Febbraio; Bente Klarlund Pedersen
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

Review 7.  Muscle-derived interleukin-6: possible biological effects.

Authors:  B K Pedersen; A Steensberg; P Schjerling
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

Review 8.  The role of interleukins in insulin resistance and type 2 diabetes mellitus.

Authors:  Bruno Fève; Jean-Philippe Bastard
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

Review 9.  Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects.

Authors:  Bente Klarlund Pedersen; Adam Steensberg; Pernille Keller; Charlotte Keller; Christian Fischer; Natalie Hiscock; Gerrit van Hall; Peter Plomgaard; Mark A Febbraio
Journal:  Pflugers Arch       Date:  2003-02-18       Impact factor: 3.657

10.  NYGGF4 homologous gene expression in 3T3-L1 adipocytes: regulation by FFA and adipokines.

Authors:  Ya-ping Zhao; Chun-mei Zhang; Chun Zhu; Xiao-hui Chen; Jia-lin Wang; Chen-bo Ji; Xia Chi; Qin Hong; Yu-zhu Peng; Xi-rong Guo
Journal:  Mol Biol Rep       Date:  2009-11-06       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.